Genetec - A baby step

CIMB Analysis: Genetec Maintains Growth Trajectory - Strong Buy Recommendation at RM3.60

Genetec A baby step
Publish date: Thu, 29 Feb 2024, 10:50 AM
Investors, let's embark on a remarkable journey together.

Give GENETEC the time it deserves, and watch our Battery Day plans flourish!

Visit my blog for insights that will empower you to make informed decisions and maximize your investment. Discover the link between company potential and industry trends: [ https://klse1.i3investor.com/blogs/genetec_rm400/blidx.jsp].

Start small, dream big, and embrace the key to success with GENETEC.

Genetec Technology showcased robust growth in its 3QFY6/24 performance, with a core net profit surge of 36% year-on-year to RM27.1

million, despite a 10% revenue decline. This growth is attributed to improved operating margins, rising to 38.6%, and strategic product mix

and cost optimization efforts. Over nine months, the company's core net profit increased by 7% to RM61.0 million, aligning with forecasts and accounting for 58% of the anticipated 15-month FY24 figures after adjusting its fiscal year-end.


Looking forward,Genetec's new venture into the Battery Energy Storage Systems (BESS)market in Malaysia, with potential tenders amounting to 2.2GWh, promises further earnings enhancement. With an attractive valuation at 15.1x FY25F P/E versus peers' 25.2x and recent stock price adjustments, Genetec stands as a compelling investment opportunity, underscoring its resilience and strategic growth potential in challenging times.


Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment